Apple-Masimo lawsuit stops sales of Apple Watch Series 9 and Ultra 2 in US temporarily
The Irvine company alleged Apple of patent infringements.
1 min. read
Published on
Share this article
Improve this guide
Read our disclosure page to find out how can you help MSPoweruser sustain the editorial team Read more
Key notes
- The Apple-Masimo lawsuit has halted the sales of Apple Watch Series 9 and Ultra 2 temporarily.
- Masimo filed a case with ITC, saying that Apple’s blood oxygen sensor tech infringes Masimo’s patents.
- The Biden administration has until Christmas to veto on ITC’s decision.
The ongoing Apple-Masimo lawsuit has temporarily halted the sales of Apple Watch Series 9 and Ultra 2 in the United States.
Apple says, in a statement to 9to5Mac, that the products won’t be available on Apple.com and official retailers starting as late as December 24.
“Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that Apple Watch is available to customers,” the statement reads.
“Should the order stand, Apple will continue to take all measures to return Apple Watch Series 9 and Apple Watch Ultra 2 to customers in the U.S. as soon as possible,” the tech giant reassures.
In 2021, Irvine-based tech company Masimo filed a case with the U.S. International Trade Commission (ITC), alleging that Apple’s blood oxygen sensor technology in the Apple Watch infringes on several of Masimo’s patents. ITC then found Apple guilty of five infringements on two patents.
The Biden administration has until December 25, 2023, to decide whether to veto the ITC’s ban on Apple Watch sales in the country. No actions are being done during what’s known as the “Presidential Review Period” so far.
